1. |
卫生部疾病预防控制局, 卫生部医政司, 中国疾病预防控制中心. 中国结核病防治规划实施工作指南[M]. 2版. 北京:人民卫生出版社, 2008:3.
|
2. |
中国防痨协会. 耐药结核病化学治疗指南(2009)[J]. 中华结核和呼吸杂志, 2010, 33(7):485-497.
|
3. |
Pozniak AL, Coyne KM, Miller RF, et al. British HIV association guidelines for the treatment of TB/HIV coinfection 2011[J]. HIV Med, 2011, 12(9):517-524.
|
4. |
National Collaborating Centre for Chronic Conditions (UK), Centre for Clinical Practice at NICE (UK). Tuberculosis:clinical diagnosis and management of tuberculosis, and measures for its prevention and control[M]. London:National Institute for Health and Clinical Excellence (UK), 2011:21.
|
5. |
Joint Tuberculosis Committee of the British Thoracic Society. Chemotherapy and management of tuberculosis in the United Kingdom:recommendations 1998[J]. Thorax, 1998, 53(7):536-548.
|
6. |
British Thoracic Society Standards of Care Committee and Joint Tuberculosis Committee, Milburn H, Ashman N, et al. Guidelines for the prevention and management of Mycobacterium tuberculosis infection and disease in adult patients with chronic kidney disease[J]. Thorax, 2010, 65(6):557-570.
|
7. |
Treatment Committee of the Japanese Society for Tuberculosis, International Exchanging committee of the Japanese Society for Tuberculosis. Clinical use of rifabutin, a rifamycin-class antibiotic, for the treatment of tuberculosis (a supplement to the 2008 revision of "standards for tuberculosis care")[J]. Kekkaku, 2011, 86(1):43.
|
8. |
Swaziland National Tuberculosis Control Programme. Drug resistant tuberculosis management guidelines and manual for Swaziland[M]. Swaziland:Ministry of Health, 2008:22-24, 30-34.
|
9. |
National Department of Health. National tuberculosis management guidelines[M]. South Africa:National Department of Health, 2009:37-39, 77, 116.
|
10. |
WHO Guidelines Approved by the Guidelines Review Committee. WHO policy on collaborative TB/HIV activities:guidelines for National programmes and other stakeholders[M]. Geneva:World Health Organization, 2012:30.
|
11. |
Ministry of Health. Guidelines for tuberculosis control in New Zealand 2010[M]. Wellington:Ministry of Health, 2010:58-61.
|
12. |
Blumberg HM, Burman WJ, Chaisson RE, et al. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America:treatment of tuberculosis[J]. Am J Respir Crit Care Med, 2003, 16(4):603-662.
|
13. |
Kaplan JE, Benson C, Holmes KK, et al. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents:recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America[J]. MMWR Recomm Rep, 2009, 58(RR-4):1-207, quiz CE1-4.
|
14. |
Masur H, Brooks JT, Benson CA, et al. Prevention and treatment of opportunistic infections in HIV-infected adults and adolescents:Updated guidelines from the Centers for Disease Control and Prevention, National Institutes of Health, and HIV Medicine Association of the Infectious Diseases Society of America[J]. Clin Infect Dis, 2014, 58(9):1308-1311.
|
15. |
Center for Disease Control and Prevention. Managing drug interactions in the treatment of HIV-related tuberculosis[EB/OL].[2014-07-17]. http://www.cdc.gov/tb/publications/guidelines/tb_hiv_drugs/default.htm.
|
16. |
Center for Disease Control and Prevention. Notice to readers:updated guidelines for the use of rifabutin or rifampin for the treatment and prevention of tuberculosis among HIV-infected patients taking protease inhibitors or nonnucleoside reverse transcriptase inhibitors[J/OL]. MMWR, 2000, 49(9):185-189[2014-07-17]. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm4909a4.htm.
|
17. |
Victorian Government Department of Human Services. Management, control and prevention of tuberculosis:guidelines for health care providers (2002-2005)[M]. Melbourne:Victorian Government Department of Human Services, 2002:13, 39.
|
18. |
Lung Association's Tuberculosis Committee. Tuberculosis information for health care providers[M/OL]. 4th ed. Ontario, Canada:Ontario Lung Association, 2009:19[2014-07-17]. http://www.on.lung.ca/Document.Doc?id=475.
|
19. |
Canadian Thoracic Society. Canadian tuberculosis standards, 7th edition[J]. Can Respir J, 2013, 20(Suppl A):40A-42A.
|
20. |
National Tuberculosis Control Programme, the National AIDS Control Programme. Guidelines for the clinical management of TB and HIV co-infection in Ghana[M]. Ghana:Ghana Health Service, 2007:31.
|
21. |
Division of Leprosy. DLTLD guidelines on management of leprosy and tuberculosis[M]. Kenya:Ministry of Public Health and Sanitation, 2009.
|
22. |
Ministry of Health Malaysia, Academy of Medicine Malaysia, Malaysian Thoracic Society. Management of tuberculosis[M]. 3rd ed. Putrajaya:Malaysia Health Technology Assessment Section, 2012:42-47.
|
23. |
World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosisL:2011 update[M]. Geneva:WHO Document Production Services, 2011:25.
|